Skip to main content

Main menu

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers

User menu

  • My alerts

Search

  • Advanced search
Annals of Family Medicine
  • My alerts
Annals of Family Medicine

Advanced Search

  • Home
  • Current Issue
  • Content
    • Current Issue
    • Early Access
    • Multimedia
    • Podcast
    • Collections
    • Past Issues
    • Articles by Subject
    • Articles by Type
    • Supplements
    • Plain Language Summaries
    • Calls for Papers
  • Info for
    • Authors
    • Reviewers
    • Job Seekers
    • Media
  • About
    • Annals of Family Medicine
    • Editorial Staff & Boards
    • Sponsoring Organizations
    • Copyrights & Permissions
    • Announcements
  • Engage
    • Engage
    • e-Letters (Comments)
    • Subscribe
    • Podcast
    • E-mail Alerts
    • Journal Club
    • RSS
    • Annals Forum (Archive)
  • Contact
    • Contact Us
  • Careers
  • Follow annalsfm on Twitter
  • Visit annalsfm on Facebook
Research ArticleResearch Briefs

Mortality Associated With Time in and Out of Buprenorphine Treatment in French Office-Based General Practice: A 7-Year Cohort Study

Julie Dupouy, Aurore Palmaro, Mélina Fatséas, Marc Auriacombe, Joëlle Micallef, Stéphane Oustric and Maryse Lapeyre-Mestre
The Annals of Family Medicine July 2017, 15 (4) 355-358; DOI: https://doi.org/10.1370/afm.2098
Julie Dupouy
1Département Universitaire de Médecine Générale, Université Toulouse III Paul Sabatier, Toulouse, France
2Inserm UMR1027, Université Toulouse III Paul Sabatier; Faculté de Médecine, Toulouse, France
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: julie.dupouy@dumg-toulouse.fr
Aurore Palmaro
2Inserm UMR1027, Université Toulouse III Paul Sabatier; Faculté de Médecine, Toulouse, France
3CEIP-Addictovigilance, CIC 1436, Service de Pharmacologie Médicale et Clinique, Faculté de Médecine, Toulouse, France
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mélina Fatséas
4Pôle Addictologie, CH Charles Perrens et CHU de Bordeaux, Bordeaux Cedex, France
5SANPSY (Addiction Psychiatry Team), CNRS USR 3413, Université de Bordeaux, PAC Carreire, Bordeaux Cedex, France
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Auriacombe
4Pôle Addictologie, CH Charles Perrens et CHU de Bordeaux, Bordeaux Cedex, France
5SANPSY (Addiction Psychiatry Team), CNRS USR 3413, Université de Bordeaux, PAC Carreire, Bordeaux Cedex, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joëlle Micallef
6CEIP-Addictovigilance Paca Corse, Service de Pharmacologie Clinique & Pharmacovigilance, Aix Marseille Université, Marseille, France
7Institut de Neurosciences Timone, CNRS 7289, secteur PIICI, Marseille, France
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stéphane Oustric
1Département Universitaire de Médecine Générale, Université Toulouse III Paul Sabatier, Toulouse, France
2Inserm UMR1027, Université Toulouse III Paul Sabatier; Faculté de Médecine, Toulouse, France
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maryse Lapeyre-Mestre
2Inserm UMR1027, Université Toulouse III Paul Sabatier; Faculté de Médecine, Toulouse, France
3CEIP-Addictovigilance, CIC 1436, Service de Pharmacologie Médicale et Clinique, Faculté de Médecine, Toulouse, France
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 15 no. 4 355-358
DOI 
https://doi.org/10.1370/afm.2098
PubMed 
28694272

Published By 
The Annals of Family Medicine
Print ISSN 
1544-1709
Online ISSN 
1544-1717
History 
  • Received for publication December 8, 2016
  • Revision received April 25, 2017
  • Accepted for publication May 9, 2017
  • Published online July 10, 2017.

Copyright & Usage 
© 2017 Annals of Family Medicine, Inc.

Author Information

  1. Julie Dupouy, MD, PhD1,2⇑,
  2. Aurore Palmaro, MSc2,3,
  3. Mélina Fatséas, MD, PhD4,5,
  4. Marc Auriacombe, MD4,5,
  5. Joëlle Micallef, MD, PhD6,7,
  6. Stéphane Oustric, MD1,2 and
  7. Maryse Lapeyre-Mestre, MD, PhD2,3
  1. 1Département Universitaire de Médecine Générale, Université Toulouse III Paul Sabatier, Toulouse, France
  2. 2Inserm UMR1027, Université Toulouse III Paul Sabatier; Faculté de Médecine, Toulouse, France
  3. 3CEIP-Addictovigilance, CIC 1436, Service de Pharmacologie Médicale et Clinique, Faculté de Médecine, Toulouse, France
  4. 4Pôle Addictologie, CH Charles Perrens et CHU de Bordeaux, Bordeaux Cedex, France
  5. 5SANPSY (Addiction Psychiatry Team), CNRS USR 3413, Université de Bordeaux, PAC Carreire, Bordeaux Cedex, France
  6. 6CEIP-Addictovigilance Paca Corse, Service de Pharmacologie Clinique & Pharmacovigilance, Aix Marseille Université, Marseille, France
  7. 7Institut de Neurosciences Timone, CNRS 7289, secteur PIICI, Marseille, France
  1. CORRESPONDING AUTHOR: Julie Dupouy, MD, PhD, Département de Médecine Générale, Faculté de Médecine, 133 route de Narbonne, 31062 Toulouse, France, julie.dupouy{at}dumg-toulouse.fr

Statistics from Altmetric.com

Article usage

Article usage: July 2017 to April 2025

AbstractFullPdf
Jul 2017870533151
Aug 201749039699
Sep 201714110428
Oct 20171363542
Nov 20171919324
Dec 2017702322
Jan 2018481821
Feb 2018771520
Mar 2018623523
Apr 2018466712
May 2018502921
Jun 2018282215
Jul 2018773922
Aug 20181136311
Sep 2018633315
Oct 2018324616
Nov 2018298319
Dec 2018429119
Jan 2019518317
Feb 201945907
Mar 2019438526
Apr 2019438123
May 2019199317
Jun 2019337612
Jul 20192812141
Aug 20193410127
Sep 2019497642
Oct 2019415423
Nov 201936369
Dec 2019242510
Jan 2020383116
Feb 2020332515
Mar 2020312114
Apr 2020341917
May 2020292110
Jun 2020342312
Jul 2020383614
Aug 2020243814
Sep 2020303512
Oct 2020254917
Nov 2020232611
Dec 2020832610
Jan 2021202913
Feb 2021294519
Mar 2021255117
Apr 202119388
May 2021125914
Jun 2021155710
Jul 2021154320
Aug 2021172110
Sep 20211613417
Oct 20211338339
Nov 20211028430
Dec 202111712
Jan 2022104713
Feb 2022147212
Mar 202211446
Apr 202278619
May 2022134822
Jun 2022135918
Jul 202210427
Aug 20226385
Sep 2022103615
Oct 202253921
Nov 2022164417
Dec 202284314
Jan 2023153816
Feb 20237198
Mar 202310356
Apr 2023133212
May 20236158
Jun 20234242
Jul 20234269
Aug 20236327
Sep 202364511
Oct 20237308
Nov 20234472
Dec 20237836
Jan 202475312
Feb 202483411
Mar 202467617
Apr 202442513
May 202431284
Jun 202432610
Jul 20243208
Aug 20245157
Sep 20244337
Oct 20244253
Nov 20241246
Dec 202432510
Jan 202522711
Feb 20251433
Mar 202524312
Apr 202543711
PreviousNext
Back to top

In this issue

The Annals of Family Medicine: 15 (4)
The Annals of Family Medicine: 15 (4)
Vol. 15, Issue 4
July/August 2017
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
  • In Brief
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Annals of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Mortality Associated With Time in and Out of Buprenorphine Treatment in French Office-Based General Practice: A 7-Year Cohort Study
(Your Name) has sent you a message from Annals of Family Medicine
(Your Name) thought you would like to see the Annals of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Mortality Associated With Time in and Out of Buprenorphine Treatment in French Office-Based General Practice: A 7-Year Cohort Study
Julie Dupouy, Aurore Palmaro, Mélina Fatséas, Marc Auriacombe, Joëlle Micallef, Stéphane Oustric, Maryse Lapeyre-Mestre
The Annals of Family Medicine Jul 2017, 15 (4) 355-358; DOI: 10.1370/afm.2098

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Get Permissions
Share
Mortality Associated With Time in and Out of Buprenorphine Treatment in French Office-Based General Practice: A 7-Year Cohort Study
Julie Dupouy, Aurore Palmaro, Mélina Fatséas, Marc Auriacombe, Joëlle Micallef, Stéphane Oustric, Maryse Lapeyre-Mestre
The Annals of Family Medicine Jul 2017, 15 (4) 355-358; DOI: 10.1370/afm.2098
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • INTRODUCTION
    • METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • References
  • Figures & Data
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • Nurse Standing Orders for Buprenorphine Follow-Up Care in a Community Health Center Network
  • Treatment of opioid use disorder in primary care
  • Narrowing the treatment gap in managing opioid use disorder
  • Now is the Time to Address Substance Use Disorders in Primary Care
  • In This Issue: Trends, Prescribing, Deprescribing
  • Google Scholar

More in this TOC Section

  • Changes in the Ambulatory Use of Antibiotics in France Due to the COVID-19 Pandemic in 2020-2022: A Nationwide Time-Series Analysis
  • Heplisav-B vs Standard Hepatitis B Vaccine Booster for Health Care Workers
  • The General Public Vastly Overestimates Primary Care Spending in the United States
Show more Research Briefs

Similar Articles

Subjects

  • Domains of illness & health:
    • Chronic illness
  • Person groups:
    • Vulnerable populations
  • Methods:
    • Quantitative methods
  • Other research types:
    • Health services

Keywords

  • opioid-related disorders
  • opioid maintenance treatment
  • buprenorphine
  • mortality
  • private practice
  • primary care
  • ambulatory care
  • cohort studies

Content

  • Current Issue
  • Past Issues
  • Early Access
  • Plain-Language Summaries
  • Multimedia
  • Podcast
  • Articles by Type
  • Articles by Subject
  • Supplements
  • Calls for Papers

Info for

  • Authors
  • Reviewers
  • Job Seekers
  • Media

Engage

  • E-mail Alerts
  • e-Letters (Comments)
  • RSS
  • Journal Club
  • Submit a Manuscript
  • Subscribe
  • Family Medicine Careers

About

  • About Us
  • Editorial Board & Staff
  • Sponsoring Organizations
  • Copyrights & Permissions
  • Contact Us
  • eLetter/Comments Policy

© 2025 Annals of Family Medicine